Acasti Pharma Operating Income 2014-2024 | GRCE
Acasti Pharma operating income from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Acasti Pharma Annual Operating Income
(Millions of US $) |
| 2024 |
$-13 |
| 2023 |
$-52 |
| 2022 |
$-16 |
| 2021 |
$-16 |
| 2020 |
$-24 |
| 2019 |
$-34 |
| 2018 |
$-15 |
| 2017 |
$-8 |
| 2016 |
$-7 |
| 2015 |
$-8 |
| 2015 |
$ |
| 2014 |
$-10 |
| 2014 |
$ |
| 2013 |
$-7 |
| 2013 |
$ |
Acasti Pharma Quarterly Operating Income
(Millions of US $) |
| 2024-06-30 |
$-5 |
| 2024-03-31 |
$-3 |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-4 |
| 2023-03-31 |
$-38 |
| 2022-12-31 |
$-4 |
| 2022-09-30 |
$-5 |
| 2022-06-30 |
$-5 |
| 2022-03-31 |
$-4 |
| 2021-12-31 |
$-4 |
| 2021-09-30 |
$-4 |
| 2021-06-30 |
$-3 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-8 |
| 2020-06-30 |
$-4 |
| 2020-03-31 |
$-4 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$-6 |
| 2019-06-30 |
$-8 |
| 2019-03-31 |
$-11 |
| 2018-12-31 |
$-8 |
| 2018-09-30 |
$-8 |
| 2018-06-30 |
$-8 |
| 2018-03-31 |
$-6 |
| 2017-12-31 |
$-4 |
| 2017-09-30 |
$-3 |
| 2017-06-30 |
$-2 |
| 2017-02-28 |
$-2 |
| 2016-11-30 |
$-2 |
| 2016-08-31 |
$-2 |
| 2016-05-31 |
$-2 |
| 2016-03-31 |
$-0 |
| 2016-02-29 |
|
| 2015-12-31 |
$-0 |
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$-3 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-3 |
| 2014-03-31 |
$0 |
| 2014-02-28 |
|
| 2013-12-31 |
$-3 |
| 2013-09-30 |
$-3 |
| 2013-06-30 |
$-2 |
| 2013-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
